Genetic control of cell differentiation in the skeleton

被引：104

作者：

Ducy, P ^{[1
]}

Karsenty, G ^{[1
]}

机构：

[1] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA

来源：

CURRENT OPINION IN CELL BIOLOGY | 1998年 / 10卷 / 05期

关键词：

D O I：

10.1016/S0955-0674(98)80037-9

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

The mechanisms of cell differentiation in the skeleton are just beginning to be unraveled. In the past year classical gene expression studies, genetic manipulation in mice and human genetic approaches have led to the identification of Osf2/Cbfa1 as a major regulator of osteoblast differentiation. important progress was also made in the understanding of the control of osteoclast differentiation through the identification of osteoprotegerin and its ligand. These studies, as well as others of chondrocyte differentiation, provide a better understanding of skeletogenesis.

引用

页码：614 / 619

页数：6

共 51 条

[21] THE RUNT DOMAIN IDENTIFIES A NEW FAMILY OF HETEROMERIC TRANSCRIPTIONAL REGULATORS
KAGOSHIMA, H
SHIGESADA, K
SATAKE, M
ITO, Y
MIYOSHI, H
OHKI, M
PEPLING, M
GERGEN, P
[J]. TRENDS IN GENETICS, 1993, 9 (10) : 338 - 341
[22] LETHAL SKELETAL DYSPLASIA FROM TARGETED DISRUPTION OF THE PARATHYROID HORMONE-RELATED PEPTIDE GENE
KARAPLIS, AC
LUZ, A
GLOWACKI, J
BRONSON, RT
TYBULEWICZ, VLJ
KRONENBERG, HM
MULLIGAN, RC
[J]. GENES & DEVELOPMENT, 1994, 8 (03) : 277 - 289
[23] Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts
Komori, T
Yagi, H
Nomura, S
Yamaguchi, A
Sasaki, K
Deguchi, K
Shimizu, Y
Bronson, RT
Gao, YH
Inada, M
Sato, M
Okamoto, R
Kitamura, Y
Yoshiki, S
Kishimoto, T
[J]. CELL, 1997, 89 (05) : 755 - 764
[24] Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation
Lacey, DL
Timms, E
Tan, HL
Kelley, MJ
Dunstan, CR
Burgess, T
Elliott, R
Colombero, A
Elliott, G
Scully, S
Hsu, H
Sullivan, J
Hawkins, N
Davy, E
Capparelli, C
Eli, A
Qian, YX
Kaufman, S
Sarosi, I
Shalhoub, V
Senaldi, G
Guo, J
Delaney, J
Boyle, WJ
[J]. CELL, 1998, 93 (02) : 165 - 176
[25] PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth
Lanske, B
Karaplis, AC
Lee, K
Luz, A
Vortkamp, A
Pirro, A
Karperien, M
Defize, LHK
Ho, C
Mulligan, RC
AbouSamra, AB
Juppner, H
Segre, GV
Kronenberg, HM
[J]. SCIENCE, 1996, 273 (5275) : 663 - 666
[26] Missense mutations abolishing DNA binding of the osteoblast-specific transcription factor OSF2/CBFA1 in cleidocranial dysplasia
Lee, B
Thirunavukkarasu, K
Zhou, L
Pastore, L
Baldini, A
Hecht, J
Geoffroy, V
Ducy, P
Karsenty, G
[J]. NATURE GENETICS, 1997, 16 (03) : 307 - 310
[27] SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha 1(II) collagen gene
Lefebvre, V
Huang, WD
Harley, VR
Goodfellow, PN
deCrombrugghe, B
[J]. MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (04) : 2336 - 2346
[28] TISSUE-SPECIFIC AND DIFFERENTIAL EXPRESSION OF ALTERNATIVELY SPLICED ALPHA-1(II) COLLAGEN MESSENGER-RNAS IN EARLY HUMAN EMBRYOS
LUI, VCH
NG, LJ
NICHOLLS, J
TAM, PPL
CHEAH, KSE
[J]. DEVELOPMENTAL DYNAMICS, 1995, 203 (02) : 198 - 211
[29] LUO GB, 1995, J BONE MINER RES, V10, P325
[30] THE TISSUE-SPECIFIC NUCLEAR MATRIX PROTEIN, NMP-2, IS A MEMBER OF THE AML/CBF/PEBP2/RUNT DOMAIN TRANSCRIPTION FACTOR FAMILY - INTERACTIONS WITH THE OSTEOCALCIN GENE PROMOTER
MERRIMAN, HL
VANWIJNEN, AJ
HIEBERT, S
BIDWELL, JP
FEY, E
LIAN, J
STEIN, J
STEIN, GS
[J]. BIOCHEMISTRY, 1995, 34 (40) : 13125 - 13132

← 1 2 3 4 5 6 →